当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析

丸美生物

(603983)

  

流通市值:160.20亿  总市值:160.20亿
流通股本:4.01亿   总股本:4.01亿

丸美生物(603983)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.86亿元,每股收益0.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益343088.97万元,未分配利润200444.85万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产476547.92万元,负债133458.94万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,769,193,475.01846,648,701.632,969,770,566.541,952,334,354.86
营业总成本1,542,793,389.93684,279,945.762,610,212,848.291,695,030,314.16
其他经营收益
营业利润241,044,718.47165,983,550.75380,936,810.22282,138,847.2
利润总额240,776,293.1166,151,487.8380,656,508.96282,160,226.33
净利润186,042,088.9135,197,697.18342,363,890.32239,788,683.89
每股收益
其他综合收益-112,116.33-59,597.35-124,364.71-53,319.78
综合收益总额185,929,972.57135,138,099.83342,239,525.61239,735,364.11
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,557,797,301.982,641,018,361.332,954,402,626.082,596,435,890.88
非流动资产:
非流动资产合计2,207,681,856.642,138,770,852.452,108,161,468.731,838,572,800.76
资产总计4,765,479,158.624,779,789,213.785,062,564,094.814,435,008,691.64
流动负债:
流动负债合计1,318,467,567.441,180,868,219.111,596,540,138.86969,555,755.82
非流动负债:
非流动负债合计16,121,842.4818,135,803.8319,520,458.1921,746,310.81
负债合计1,334,589,409.921,199,004,022.941,616,060,597.05991,302,066.63
所有者权益(或股东权益):
归属于母公司股东权益合计3,365,535,062.953,515,392,384.833,380,406,892.853,377,359,780.47
股东权益合计3,430,889,748.73,580,785,190.843,446,503,497.763,443,706,625.01
负债和股东权益合计4,765,479,158.624,779,789,213.785,062,564,094.814,435,008,691.64
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,775,691,102.87954,056,827.42,777,639,441.461,920,298,243.91
经营活动现金流出小计1,660,043,855.72981,644,388.672,477,112,583.111,851,874,733.42
经营活动产生的现金流量净额115,647,247.15-27,587,561.27300,526,858.3568,423,510.49
投资活动产生的现金流量:
投资活动现金流入小计157,330,350.3796,330,024.031,400,120,250.131,052,260,842.69
投资活动现金流出小计235,365,414.78124,236,457.12967,928,649.87757,875,811.57
投资活动产生的现金流量净额-78,035,064.41-27,906,433.09432,191,600.27294,385,031.12
筹资活动产生的现金流量:
筹资活动现金流入小计415,388,536.34-786,676,783.33379,518,827.78
筹资活动现金流出小计772,550,724.5151,633,336.23979,825,800.28467,388,143.43
筹资活动产生的现金流量净额-357,162,188.16-151,633,336.23-193,149,016.95-87,869,315.65
汇率变动对现金及现金等价物的影响124,244.9820,332.55-48,386.26-35,217.93
现金及现金等价物净增加额-319,425,760.44-207,106,998.04539,521,055.4274,904,008.03
期末现金及现金等价物余额1,259,634,249.51,371,953,011.91,579,060,009.941,314,442,962.57
补充资料:
现金及现金等价物的净增加额-319,425,760.44-539,521,055.4-
最新报告期:2025-09-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长江证券李锦,罗祎1.061.431.782025-09-11
长城证券黄淑妍1.061.311.592025-09-03
中信证券张琳,徐晓芳,杜一帆1.101.421.792025-08-27
华源证券丁一1.051.351.672025-08-27
天风证券何富丽1.081.361.672025-08-27
TOP↑